OpenEvidence has 5 close competitors: Devoted Health, Neuralink, Epic Systems.
Sector, valuation and status for each competitor.
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
Devoted HealthNeuralinkEpic SystemsAbridgeOpenEvidence develops an AI-powered medical search engine used by healthcare professionals for clinical decision support, licensing content from major medical journals and societies.
OpenEvidence competes with 5 companies here: Devoted Health, Neuralink, Epic Systems, Abridge, Alloy Therapeutics.
OpenEvidence was last valued at $12B (post-money, Jan 2026). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The routes section explains what is realistically available for a company at this stage.
No. OpenEvidence is a private company; its shares do not trade on a public exchange.
The last valuation is $12B.
Lead investors for each round are in the funding timeline.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
